Evidence map›Paper›PMID 39656479›Full record

ArticleJournal of cellular and molecular medicine2024

Building a Risk Scoring Model for ARDS in Lung Adenocarcinoma Patients Using Machine Learning Algorithms.

Erchun Hong, Yunyun Sun, Yongming Qin, Wenjun Zhao, Yanzi Qin, Xincan Li, Liang Zhang

Abstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Erchun HongDepartment of Emergency Medicine, Bengbu Third People's Hospital, Bengbu Medical University, Bengbu, Anhui Province, China.
Yunyun SunDepartment of Neurology, Bengbu Third People's Hospital, Bengbu Medical University, Bengbu, Anhui Province, China.
Yongming QinDepartment of Emergency Medicine, Bengbu Third People's Hospital, Bengbu Medical University, Bengbu, Anhui Province, China.
Wenjun ZhaoDepartment of Emergency Medicine, Bengbu Third People's Hospital, Bengbu Medical University, Bengbu, Anhui Province, China.
Yanzi QinDepartment of Pathology, Bengbu Medical University, Bengbu, Anhui Province, China.
Xincan LiDepartment of Emergency Medicine, Bengbu Third People's Hospital, Bengbu Medical University, Bengbu, Anhui Province, China.
Liang ZhangDepartment of Emergency Medicine, Bengbu Third People's Hospital, Bengbu Medical University, Bengbu, Anhui Province, China.ORCID 0009-0002-6547-6600

Funding

Bengbu Third People's Hospital affiliated with Bengbu Medical University-Culture Programme BBSYpyky202307011Department of Education of Anhui Province-Anhui Province Higher School Scientific Research Project 2023AH0519911
6 · The paper itself

Abstract

Lung adenocarcinoma (LUAD), the predominant form of non-small-cell lung cancer, is frequently complicated by acute respiratory distress syndrome (ARDS), which increases mortality risks. Investigating the prognostic implications of ARDS-related genes in LUAD is crucial for improving clinical outcomes. Data from TCGA, GEO and GTEx were used to identify 276 ARDS-related genes in LUAD via differential expression analysis. Univariate Cox regression, consensus clustering and machine learning algorithms were used to develop a prognostic risk scoring model. Functional enrichment, immune infiltration analyses, copy number variations and mutational burdens were examined, and the results were validated at the single-cell level. ARDS-related genes significantly impact the prognosis of LUAD patients. A machine learning-based risk scoring model accurately predicted survival rates. Functional enrichment and immune infiltration analyses revealed that these genes are primarily involved in cell cycle regulation and immune cell infiltration. Single-cell expression data supported these findings, and the assessments of copy number variations and mutational burdens highlighted distinct genetic characteristics. This study establishes the prognostic relevance of ARDS-associated genes in LUAD and provides potential biomarkers for personalized therapy and prognosis. Future studies will validate these findings and explore their clinical applications.

Indexed as

Adenocarcinoma of LungLung NeoplasmsMachine LearningRespiratory Distress SyndromeAlgorithmsBiomarkers, TumorDNA Copy Number VariationsFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticHumansMaleMutationPrognosisRisk AssessmentRisk FactorsBiomarkers, Tumoracute respiratory distress syndromebiomarkerslung adenocarcinomarisk scoring model

Identifiers

PMID39656479
PMCPMC11629804

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.